Cargando…

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

The 14th St Gallen International Breast Cancer Conference (2015) reviewed substantial new evidence on locoregional and systemic therapies for early breast cancer. Further experience has supported the adequacy of tumor margins defined as ‘no ink on invasive tumor or DCIS’ and the safety of omitting a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coates, A. S., Winer, E. P., Goldhirsch, A., Gelber, R. D., Gnant, M., Piccart-Gebhart, M., Thürlimann, B., Senn, H.-J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Special Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511219/ https://www.ncbi.nlm.nih.gov/pubmed/25939896 http://dx.doi.org/10.1093/annonc/mdv221

Ejemplares similares

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
por: Goldhirsch, A., et al.
Publicado: (2009)

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
por: Goldhirsch, A., et al.
Publicado: (2011)

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
por: Goldhirsch, A., et al.
Publicado: (2013)

Customizing early breast cancer therapies – The 2021 St. Gallen International Breast Cancer Consensus Conference()
por: Gnant, Michael, et al.
Publicado: (2022)

Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
por: Burstein, H.J., et al.
Publicado: (2021)

St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer
por: Thomssen, Christoph, et al.
Publicado: (2021)

Primary therapy of early breast cancer: Egyptian view of 2021 St. Gallen consensus
por: Khaled, Hussein, et al.
Publicado: (2022)

Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: German Expert Opinions on the 17th International St. Gallen Consensus Conference
por: Untch, Michael, et al.
Publicado: (2021)

Comparison of 21-gene assay and St.Gallen International Expert Consensus in the treatment decision for patients with early invasive breast cancers
por: Luo, Ming, et al.
Publicado: (2019)

Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists on the 16th St. Gallen International Breast Cancer Conference (Vienna 2019)
por: Untch, Michael, et al.
Publicado: (2019)

Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer
por: Bauer, Katrina, et al.
Publicado: (2010)

Treatment of Early Breast Cancer: The 18th St. Gallen International Breast Cancer Consensus Conference against the Background of Current German Treatment Recommendations
por: Untch, Michael, et al.
Publicado: (2023)

Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer
por: Ribi, K, et al.
Publicado: (2012)

Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG).
por: Bernhard, J., et al.
Publicado: (1998)

Highlights from the 15th St Gallen International Breast Cancer Conference 15–18 March, 2017, Vienna: tailored treatments for patients with early breast cancer
por: Morigi, Consuelo
Publicado: (2017)

8th International Conference: Primary Therapy of Early Breast Cancer, St Gallen, Switzerland, March 12–15 2003
por: Glen, Hilary, et al.
Publicado: (2003)

PROCURE European consensus on breast cancer multigene signatures in early breast cancer management
por: Curigliano, Giuseppe, et al.
Publicado: (2023)

Targeting immune checkpoints in breast cancer: an update of early results
por: Solinas, Cinzia, et al.
Publicado: (2017)

Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
por: Regan, Meredith M, et al.
Publicado: (2011)

Differences in Clinical Outcomes between Luminal A and B Type Breast Cancers according to the St. Gallen Consensus 2013
por: Ahn, Hyo Jung, et al.
Publicado: (2015)

Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials()
por: Pala, Laura, et al.
Publicado: (2023)

Highlights of the 17th St Gallen International Breast Cancer Conference 2021: customising local and systemic therapies
por: Reinert, Tomás, et al.
Publicado: (2021)

Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain study
por: Gómez-Acebo, Inés, et al.
Publicado: (2021)

Bisphosphonates in the adjuvant treatment of early breast cancer
por: Gnant, M
Publicado: (2009)

Application of St Gallen Categories in Predicting Survival for Patients With Breast Cancer in Vietnam
por: Nguyen, Van Chu, et al.
Publicado: (2019)

Accelerating progress in early triple-negative breast cancer: A viewpoint on antibody-drug conjugates, back from St Gallen breast cancer conference 2021()
por: Trapani, Dario, et al.
Publicado: (2021)

Systemic therapy for early-stage breast cancer: learning from the past to build the future
por: Agostinetto, Elisa, et al.
Publicado: (2022)

The evolving role of zoledronic acid in early breast cancer
por: Gnant, Michael
Publicado: (2009)

Prognostic significance of Ki67 in Chinese women diagnosed with ER(+)/HER2(−) breast cancers by the 2015 St. Gallen consensus classification
por: Hu, Yue, et al.
Publicado: (2017)

Update Breast Cancer 2023 Part 3 – Expert Opinions of Early Stage Breast Cancer Therapies
por: Kolberg, Hans-Christian, et al.
Publicado: (2023)

The AURORA initiative for metastatic breast cancer
por: Zardavas, D, et al.
Publicado: (2014)

New generation of breast cancer clinical trials implementing molecular profiling
por: Zardavas, Dimitrios, et al.
Publicado: (2016)

Highlights of the 16th St Gallen International Breast Cancer Conference, Vienna, Austria, 20–23 March 2019: personalised treatments for patients with early breast cancer
por: Morigi, Consuelo
Publicado: (2019)

St.Gallen consensus on safe implementation of transanal total mesorectal excision
por: Adamina, Michel, et al.
Publicado: (2017)

Cyclin-dependent kinases 4 and 6 inhibitors (CDK4/6i) versus chemotherapy in luminal B early breast cancer: lessons from the CORALLEEN trial
por: De Angelis, Claudia, et al.
Publicado: (2020)

Validity of St Gallen risk categories in prognostication of breast cancer patients in Southern Sri Lanka
por: Peiris, Harshini, et al.
Publicado: (2018)

Highlights from the 14(th) St Gallen International Breast Cancer Conference 2015 in Vienna: Dealing with classification, prognostication, and prediction refinement to personalize the treatment of patients with early breast cancer
por: Esposito, Angela, et al.
Publicado: (2015)

The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus
por: Kaidar-Person, Orit, et al.
Publicado: (2023)

Targeted therapies in breast cancer: are heart and vessels also being targeted?
por: Criscitiello, Carmen, et al.
Publicado: (2012)

Prevention of bone metastases and management of bone health in early breast cancer
por: Gnant, Michael, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_o8v3lukdddekf996fs5gh2dikh